Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
427 hedge funds and large institutions have $6.84B invested in Shockwave Medical, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 145 increasing their positions, 150 reducing their positions, and 65 closing their positions.
62% more call options, than puts
Call options by funds: $141M | Put options by funds: $87.3M
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
29% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 65
4% more funds holding
Funds holding: 412 → 427 (+15)
0% less capital invested
Capital invested by funds: $6.85B → $6.84B (-$19.1M)
3% less repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 150
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$126M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$98.7M |
| 3 |
Morgan Stanley
New York
|
+$70.4M |
| 4 |
Amundi
Paris,
France
|
+$60.4M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$58.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$99.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$85.6M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$84.8M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$63M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$48.6M |
SWAV Hedge Fund Activity: Q4 2023 in Review
427 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q4 2023, worth a combined $6.84B — down 0.28% from $6.85B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new SWAV positions and 65 closed out — a net gain of 19 holders — while 145 added to existing stakes and 150 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $126M. The largest seller was Fidelity Investments, cutting an estimated $99.7M.
- 427 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q4 2023, up from 412 in Q3 2023.
- Funds reported $6.84B of Shockwave Medical, Inc. Common Stock stock for Q4 2023, down 0.28% quarter-over-quarter.
- 84 funds opened new Shockwave Medical, Inc. Common Stock positions in Q4 2023 and 65 closed out, a net change of +19 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q4 2023 was Wellington Management Group, an estimated $126M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q4 2023 was Fidelity Investments, an estimated $99.7M sold.
Based on aggregated 13F filings for Q4 2023.